Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

O

ORKA

Oruka Therapeutics Inc

96.75

Aug 04 • 11:49 AM ET +1.96 (2.06%)

Healthcare Biotechnology USA Mid NASD

Peers: KRYS RYTM BMRN VKTX INCY AXSM MDGL ALNY KROS NBIX

| Held by: VTI XBI IWM VXF IWO IBB TCAF VTWO SCHA CGMM

Scroll to Statements

Index	RUT
Market Cap	5.83B
Enterprise Value	5.45B
Income	-116.25M
Sales	0.00M
Book/sh	9.64
Cash/sh	6.45
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	68
IPO	Aug 08, 1997

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	10.03
P/C	15.01
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	23.76
Current Ratio	23.76
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-2.39
EPS next Y	-2.51
EPS next Q	-0.51
EPS this Y	-14.20%
EPS next Y	-19.01%
EPS next 5Y	-22.28%
EPS past 3/5Y	34.61% 37.79%
Sales past 3/5Y	- -
EPS Y/Y TTM	54.61%
Sales Y/Y TTM	-
EPS Q/Q	-14.47%
Sales Q/Q	-
Earnings	May 13 AMC
EPS/Sales Surpr.	12.23% -

Insider Own	15.77%
Insider Trans	-28.49%
Inst Own	78.62%
Inst Trans	0.82%
ROA	-26.37%
ROE	-27.31%
ROIC	-23.83%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	6.83%
SMA50	21.84%
SMA200	94.67%
Trades

Shs Outstand	60.31M
Shs Float	50.80M
Short Float	17.39%
Short Ratio	6.28
Short Interest	8.83M
52W High	99.00 -2.28%
52W Low	12.84 653.47%
Volatility	7.16% 6.00%
ATR (14)	5.30
RSI (14)	61.87
Beta	-0.31
Rel Volume	0.26
Avg Volume	1.41M
Volume	141,485

Perf Week	6.96%
Perf Month	16.38%
Perf Quarter	45.57%
Perf Half Y	182.06%
Perf YTD	219.19%
Perf Year	576.54%
Perf 3Y	634.82%
Perf 5Y	409.87%
Perf 10Y	-73.14%
Recom	1.07
Target Price	146.85
Prev Close	94.79
Price	96.75
Change	2.06%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)